iShares Biotechnology ETF $IBB Stock Sold by Investment House LLC

Investment House LLC lowered its stake in iShares Biotechnology ETF (NASDAQ:IBB) by 25.6% in the third quarter, HoldingsChannel.com reports. The firm owned 71,956 shares of the financial services provider’s stock after selling 24,759 shares during the quarter. iShares Biotechnology ETF comprises 0.7% of Investment House LLC’s investment portfolio, making the stock its 29th largest position. Investment House LLC’s holdings in iShares Biotechnology ETF were worth $15,149,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also modified their holdings of the company. SBI Securities Co. Ltd. lifted its holdings in iShares Biotechnology ETF by 81.1% during the 3rd quarter. SBI Securities Co. Ltd. now owns 2,789 shares of the financial services provider’s stock worth $587,000 after buying an additional 1,249 shares in the last quarter. Marion Wealth Management boosted its position in iShares Biotechnology ETF by 0.5% in the 3rd quarter. Marion Wealth Management now owns 19,807 shares of the financial services provider’s stock valued at $4,170,000 after buying an additional 98 shares during the last quarter. Massachusetts Wealth Management increased its stake in shares of iShares Biotechnology ETF by 35.7% in the 3rd quarter. Massachusetts Wealth Management now owns 6,031 shares of the financial services provider’s stock valued at $1,270,000 after buying an additional 1,585 shares during the period. Magnus Financial Group LLC increased its stake in shares of iShares Biotechnology ETF by 10.7% in the 3rd quarter. Magnus Financial Group LLC now owns 9,472 shares of the financial services provider’s stock valued at $1,994,000 after buying an additional 916 shares during the period. Finally, Axxcess Wealth Management LLC acquired a new stake in shares of iShares Biotechnology ETF in the 3rd quarter valued at $424,000. Institutional investors and hedge funds own 62.45% of the company’s stock.

iShares Biotechnology ETF Stock Performance

IBB stock opened at $209.54 on Friday. iShares Biotechnology ETF has a twelve month low of $153.50 and a twelve month high of $217.12. The business has a fifty day moving average of $207.69 and a 200-day moving average of $189.17.

iShares Biotechnology ETF Cuts Dividend

The company also recently declared a quarterly dividend, which was paid on Friday, September 18th. Investors of record on Tuesday, September 15th were issued a $0.0112 dividend. This is a negative change from iShares Biotechnology ETF’s previous quarterly dividend of $0.0238. This represents a $0.04 annualized dividend and a yield of 0.0%. The ex-dividend date was Tuesday, September 15th.

iShares Biotechnology ETF Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.